In addition, CPX treatment remarkably reduced Ki67 (a cell proliferation marker) expression in tumor tissues of NSCLC xenograft mouse models, compared with that of 0.9% NaCl treatment. The gene discussed is MKI67; the disease is non-small cell lung carcinoma.